The Latest Headlines at American Banking and Market News
Raymond James & Associates Raises Stock Holdings in Capital Southwest Co. (NASDAQ:CSWC)
Raymond James & Associates grew its stake in Capital Southwest Co. (NASDAQ:CSWC – Free Report) by 15.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
TFI International (NYSE:TFII) Given New $166.00 Price Target at Bank of America
TFI International (NYSE:TFII – Free Report) had its target price lifted by Bank of America from $154.00 to $166.00 in a research note released on Monday morning, Benzinga reports. They currently have a neutral rating on the stock. Several... More of this article »
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Major Shareholder Perceptive Advisors Llc Buys 2,353,000 Shares
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) major shareholder Perceptive Advisors Llc bought 2,353,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The stock was... More of this article »
Raymond James & Associates Purchases 8,204 Shares of JELD-WEN Holding, Inc. (NYSE:JELD)
Raymond James & Associates increased its position in shares of JELD-WEN Holding, Inc. (NYSE:JELD – Free Report) by 6.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities... More of this article »
Wells Fargo & Company (NYSE:WFC) Upgraded to “Hold” by StockNews.com
StockNews.com upgraded shares of Wells Fargo & Company (NYSE:WFC) from a sell rating to a hold rating in a research note issued to investors on Monday. WFC has been the subject of a number of other research reports. The Goldman... More of this article »
Argan (NYSE:AGX) Upgraded by StockNews.com to Strong-Buy
StockNews.com upgraded shares of Argan (NYSE:AGX – Free Report) from a buy rating to a strong-buy rating in a report issued on Monday morning. Separately, Lake Street Capital increased their price target on shares of Argan from... More of this article »
Raymond James & Associates Cuts Stock Holdings in Franklin Resources, Inc. (NYSE:BEN)
Raymond James & Associates lowered its stake in shares of Franklin Resources, Inc. (NYSE:BEN – Free Report) by 90.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities... More of this article »
Boston Scientific (NYSE:BSX) Given New $78.00 Price Target at Royal Bank of Canada
Boston Scientific (NYSE:BSX – Free Report) had its price objective lifted by Royal Bank of Canada from $70.00 to $78.00 in a report published on Monday, Benzinga reports. Royal Bank of Canada currently has an outperform rating... More of this article »
American Express (NYSE:AXP) Lowered to Hold at StockNews.com
StockNews.com cut shares of American Express (NYSE:AXP) from a buy rating to a hold rating in a research report report published on Monday. AXP has been the subject of several other research reports. Royal Bank of Canada raised their... More of this article »
Raymond James & Associates Sells 7,317 Shares of Sprout Social, Inc. (NASDAQ:SPT)
Raymond James & Associates lowered its stake in Sprout Social, Inc. (NASDAQ:SPT – Free Report) by 15.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.... More of this article »
Oak Valley Bancorp (NASDAQ:OVLY) Stock Price Passes Below Two Hundred Day Moving Average of $25.69
Oak Valley Bancorp (NASDAQ:OVLY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $25.69 and traded as low as $23.12. Oak Valley... More of this article »
Schneider National (NYSE:SNDR) Given New $23.00 Price Target at Bank of America
Schneider National (NYSE:SNDR – Free Report) had its price target reduced by Bank of America from $25.00 to $23.00 in a report published on Monday, Benzinga reports. Bank of America currently has a neutral rating on the stock. A... More of this article »
Bristol-Myers Squibb (NYSE:BMY) Downgraded by StockNews.com to “Buy”
StockNews.com lowered shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from a strong-buy rating to a buy rating in a report issued on Monday morning. Several other research firms have also recently issued reports on BMY.... More of this article »